Your basket is currently empty!
» Kidney Cancer News » Standard vs Modified Drug Therapy in Renal Cancer
Standard vs Modified Drug Therapy in Renal Cancer
A randomised multi stage, phase II/III trial of Standard first-line therapy (sunitinib or pazopanib) comparing temporary cessation with allowing continuation, in the treatment of locally advanced and/or metastatic renal cancer. Please click here to find out more.
Kidney Cancer UK
Kidney Cancer UK is the UK’s leading kidney cancer charity. We seek to reduce the harm caused by kidney cancer by increasing knowledge and awareness, providing patient information and by supporting research into the causes, prevention and treatment of the disease
Donate
With your help we can beat kidney cancer together
